
|Articles|October 30, 2015
Drug Pricing Controversy Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/drug-pricing-controversy-highlights-specialty-phar" target="_blank">View the story "Drug Pricing Controversy Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Etuvetidigene Autotemcel, First Gene Therapy for Wiskott-Aldrich Syndrome
2
Experts Weigh In on GLP-1 Agonist Use in Pediatric Patients with Obesity
3
How Next-Generation CDK Inhibitors Are Redefining Post–CDK4/6 Therapy in HR+/HER2– Metastatic Breast Cancer
4
Automation and Standardization Take Center Stage in Health System’s Centralized IV Compounding Strategy
5


















































































































































































































